Article Information
- Received May 1, 2024
- Revision received May 20, 2024
- Accepted May 22, 2024
- Published online July 18, 2024.
Author Information
- Artur Silva1,*,
- Paulo Carriço1,*,
- Ana B. Fernandes1,2,
- Tatiana Saraiva1,3,
- Albino J. Oliveira-Maia1,2,4 and
- Joaquim Alves da Silva1,2
- 1Champalimaud Research, Champalimaud Foundation, 1400-038 Lisbon, Portugal
- 2NOVA Medical School, Faculdade de Ciências Médicas da Universidade Nova de Lisboa, 1169-056 Lisbon, Portugal
- 3Department of Neurology, University Hospital of Würzburg, 97080 Würzburg, Germany
- 4Champalimaud Clinical Centre, Champalimaud Foundation, 1400-038 Lisbon, Portugal
- Correspondence should be addressed to Joaquim Alves da Silva at joaquim.silva{at}neuro.fchampalimaud.org.
Author contributions
Author contributions: A.S., P.C., A.J.O.-M., and J.A.S. designed research; P.C., A.B.F., and T.S. performed research; A.S. and J.A.S. analyzed data; A.S., P.C., A.B.F., A.J.O.-M., and J.A.S. wrote the paper.
Disclosures
A.J.O.-M. was a national coordinator for Portugal of a noninterventional study (EDMS-ERI-143085581, 4.0) to characterize a treatment-resistant depression cohort in Europe, sponsored by Janssen-Cilag, Ltd. (2019–2020), a trial of psilocybin therapy for treatment-resistant depression, sponsored by Compass Pathways (EudraCT number 2017-003288-36), and a trial of esketamine for treatment-resistant depression, sponsored by Janssen-Cilag (EudraCT NUMBER: 2019-002992-33). In the past 3 years, he received payment, honoraria, or other support from Angelini, Janssen, MSD, Neurolite AG, and the European Monitoring Centre for Drugs and Drug Addiction. He is vice-president of the Portuguese Society for Psychiatry and Mental Health. None of the aforementioned agencies had a role in the preparation, review, or approval of the manuscript or in the decision to submit the manuscript for publication. Other authors report no conflict of interest.
We thank Hugo Marques for a thoughtful review and feedback on this manuscript. J.A.S. was supported by the Portuguese Foundation for Technology and Science (FCT) CEEC Grant (2020.03118.CEECIND). A.B.F., A.J.O.-M. and J.A.S. were supported by the FCT grants PTDC/MED-NEU/1552/2021 and PTDC/SAU-NUT/3507/2021.
↵*A.S. and P.C. are the co-first authors.
Funding
MEC | Fundação para a Ciência e a Tecnologia (FCT)
2020.03118.CEECIND; PTDC/MED-NEU/1552/2021; PTDC/SAU-NUT/3507/2021
Article usage
In this issue
